Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Pediatrics. 2022 Mar 1;149(3). doi: 10.1542/peds.2021-052130.
Genetic testing is expanding among ill neonates, yet the influence of genetic results on medical decision-making is not clear. With this study, we sought to determine how different types of genetic information with uncertain implications for prognosis influence clinicians' decisions to recommend intensive versus palliative care.
We conducted a national study of neonatologists using a split sample experimental design. The questionnaire contained 4 clinical vignettes. Participants were randomly assigned to see one of 2 versions that varied only regarding whether they included the following genetic findings: (1) a variant of uncertain significance; (2) a genetic diagnosis that affects neurodevelopment but not acute survival; (3) a genetic versus nongenetic etiology of equally severe pathology; (4) a pending genetic testing result. Physicians answered questions about recommendations they would make for the patient described in each vignette.
Vignette versions that included a variant of uncertain significance, a diagnosis foreshadowing neurodevelopmental impairment, or a genetic etiology of disease were all associated with an increased likelihood of recommending palliative rather than intensive care. A pending genetic test result did not have a significant effect on care recommendations.
Findings from this study of hypothetical cases suggest neonatologists apply uncertain genetic findings or those that herald neurodevelopmental disability in problematic ways. As genetic testing expands, understanding how it is used in decision-making and educating clinicians regarding appropriate use are paramount.
遗传检测在患病新生儿中的应用正在不断扩大,但遗传检测结果对医疗决策的影响尚不清楚。本研究旨在确定不同类型的遗传信息对预后的影响程度如何,进而影响临床医生推荐强化治疗与姑息治疗的决策。
我们采用拆分样本实验设计,对新生儿科医生进行了一项全国性研究。调查问卷包含 4 个临床病例。参与者被随机分配到 2 个版本中的一个,这两个版本仅在是否包含以下遗传发现方面有所不同:(1)意义不明的变异;(2)影响神经发育但不影响急性生存的遗传诊断;(3)遗传与非遗传病因导致的同等严重病理;(4)待定的遗传检测结果。医生回答了与每个病例描述的患者相关的推荐建议问题。
包含意义不明的变异、预示神经发育障碍的诊断或疾病遗传病因的病例版本,均与推荐姑息治疗而非强化治疗的可能性增加有关。待定的遗传检测结果对护理建议没有显著影响。
本研究对假设病例的研究结果表明,新生儿科医生以有问题的方式应用不确定的遗传发现或预示神经发育障碍的发现。随着遗传检测的广泛应用,了解其在决策中的应用方式并对临床医生进行适当应用的教育至关重要。